US Patent Issued to BRYET US on Aug. 19 for "Compositions for targeted delivery of therapeutic agents and methods for the synthesis and use thereof" (Washington Inventor)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,420, issued on Aug. 19, was assigned to BRYET US INC. (Houston).

"Compositions for targeted delivery of therapeutic agents and methods for the synthesis and use thereof" was invented by Masakatsu Eguchi (Bellevue, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions and methods for delivering therapeutic agents to particular tissues or cells in a subject. The composition disclosed herein combines unique properties of porous micro- or nano-particles with host-guest chemistry provided by functionalized silicon particle, offering a versatile approach to addressing the challenges associated with delivering th...